Donoghue Forlines LLC Merck & Co., Inc. Transaction History

Donoghue Forlines LLC

$342 Million
Q2 2024

A detailed history of Donoghue Forlines LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Donoghue Forlines LLC holds 15,389 shares of MRK stock, worth $1.75 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

15,389

Previous 15,372 0.11%

Holding current value

$1.75 Million

Previous $2.03 Million 6.07%

% of portfolio

0.56%

Previous 0.6%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$123.8 - $132.96 $2,104 - $2,260	17 Added 0.11%	15,389 $1.91 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $70,888 - $82,600	626 Added 4.25%	15,372 $2.03 Million
Q4 2023 Feb 07, 2024	SELL	$100.18 - $109.02 $94,069 - $102,369	-939 Reduced 5.99%	14,746 $1.61 Million
Q3 2023 Nov 06, 2023	BUY	$102.95 - $114.33 $128,996 - $143,255	1,253 Added 8.68%	15,685 $1.61 Million
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $642,536 - $700,336	-5,916 Reduced 29.07%	14,432 $1.67 Million
Q1 2023 May 08, 2023	SELL	$102.94 - $114.86 $598,184 - $667,451	-5,811 Reduced 22.21%	20,348 $2.16 Million
Q4 2022 Feb 08, 2023	BUY	$87.44 - $112.11 $1.11 Million - $1.42 Million	12,654 Added 93.7%	26,159 $2.9 Million
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $616,899 - $693,018	-7,298 Reduced 35.08%	13,505 $1.16 Million
Q2 2022 Aug 08, 2022	SELL	$83.49 - $94.64 $239,950 - $271,995	-2,874 Reduced 12.14%	20,803 $1.9 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $462,598 - $518,543	-6,293 Reduced 21.0%	23,677 $1.94 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $2.17 Million - $2.71 Million	29,970 New	29,970 $2.3 Million
Q4 2020 Feb 09, 2021	SELL	$71.77 - $79.65 $1.01 Million - $1.12 Million	-14,034 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $1.03 Million - $1.16 Million	14,034 New	14,034 $1.16 Million
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $698,003 - $794,248	-9,912 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $1.7 Million - $2.36 Million	-26,881 Reduced 73.06%	9,912 $763,000
Q4 2019 Jan 27, 2020	BUY	$77.58 - $87.54 $2.85 Million - $3.22 Million	36,793 New	36,793 $3.35 Million
Q4 2018 Jan 24, 2019	SELL	$65.24 - $75.71 $12.6 Million - $14.6 Million	-192,500 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$57.69 - $67.84 $3.77 Million - $4.43 Million	-65,285 Reduced 25.33%	192,500 $13.7 Million
Q2 2018 Jul 26, 2018	SELL	$50.83 - $59.72 $3.39 Million - $3.99 Million	-66,741 Reduced 20.57%	257,785 $15.6 Million
Q1 2018 May 03, 2018	BUY	$50.96 - $59.23 $219,077 - $254,629	4,299 Added 1.34%	324,526 $17.7 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $3.55 Million - $4.24 Million	68,822 Added 27.37%	320,227 $18 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $75,801 - $81,563	1,292 Added 0.52%	251,405 $16.1 Million
Q2 2017 Sep 12, 2017	BUY	N/A	250,113	250,113 $16 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donoghue Forlines LLC with notifications on news.

Account

Donoghue Forlines LLC Merck & Co., Inc. Transaction History